Understanding and targeting anoikis in metastasis for cancer therapies
Cell Biology International · 2023-04 · 47 (4) · 683-698
DOI: 10.1002/cbin.11970 ↗At a glance
Übersichtsarbeit in Cell Biology International, 2022-12. Written by Farzad Sattari Fard and 4 co-authors. Institution: Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Major MEDLINE topics: Anoikis, Neoplasms. Cited 67 times so far (Crossref); 137 references. Funded by: Immunology research center, Tabriz, Iran.
Abstract (original language)
The development of effective treatments for cancers requires investigations for a more detailed and comprehensive understanding of the basic cellular mechanisms involved in carcinogenesis, cancer progression, and metastasis. One of those driving mechanisms is anoikis, a special type of apoptosis, which is induced by losing anchorage from the extracellular matrix (ECM). In other words, resisting death in detached cells (cells without ECM) forms an anoikis‐resistant phenotype. Since the anoikis‐resistance state compensates for the initial steps of cancer metastasis, this review aimed to discuss mechanisms of gaining anoikis/anoikis resistance phenotype in tumor cells. Finally, we highlighted the significance of anoikis in malignancies so as to provide clear insight into cancer diagnosis and therapy development.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Anatomical Sciences, School of Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Radiology, Faculty of Para-Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Funding
- Immunology research center, Tabriz, Iran
Cite
APA
Sattari Fard, F., Jalilzadeh, N., Mehdizadeh, A., Sajjadian, F., & Velaei, K. (2023). Understanding and targeting anoikis in metastasis for cancer therapies. Cell Biology International, 47(4), 683-698. https://doi.org/10.1002/cbin.11970
Vancouver
Sattari Fard F, Jalilzadeh N, Mehdizadeh A, Sajjadian F, Velaei K. Understanding and targeting anoikis in metastasis for cancer therapies. Cell Biology International. 2023;47(4):683-698. doi:10.1002/cbin.11970
BibTeX
@article{SattariFard2023,
author = {Sattari Fard, Farzad and Jalilzadeh, Nazila and Mehdizadeh, Amir and Sajjadian, Fakhrosadat and Velaei, Kobra},
title = {Understanding and targeting anoikis in metastasis for cancer therapies},
journal = {Cell Biology International},
year = {2023},
volume = {47},
number = {4},
pages = {683--698},
doi = {10.1002/cbin.11970}
}
EUVIMED